The Life ILS Conference returns to London on Tuesday, May 20th , 2025. Hosted by Life Risk News, this must-attend conference will bring industry peers together to cover the latest market insights, news and trends in the Life ILS space.
The in person conference will be held over a full-day at EY’s Canary Wharf offices in London, UK. We will also be providing a virtual broadcast option to those unable to attend in person.
Exploring how the life risk markets introduce a global potential, forecasting a surge in demand and innovation.
Unpacking the emergence of new possibilities for transferring longevity and mortality risk and leveraging secondary markets to foster extra liquidity.
Delving deep into the effects of varying mortality rates among distinct groups.
Engaging in discussions on the enduring resilience of the longevity and mortality risk markets in the face of economic fluctuations and unpredictable variables.
We were also excited to offer a number of sponsorship opportunities to help you showcase your firm, build new relationships and develop your brand recognition. Put your business in the spotlight and engage and interact with the Life ILS industry at this unique event. For more details reach out to our conference facilitator.
Video recordings of the 2024 event are available on the Past Event Videos page. For the password please email us at admin@elsa-sls.org. If you have any questions please do not hesitate to reach out to ELSA at info@elsa-sls.org.
Please note due to capacity restrictions, outside of ELSA’s control, registration spaces in London will be allocated on a first come, first serve basis. In addition, in the event that the physical venues are required to be cancelled or have their capacity reduced ELSA will endeavor to host the conference virtually.
We will bring over 200+ market participants together for an insightful day of Life ILS content and networking opportunities.
The Life ILS conference brings a range of speakers together to present on the future of mortality and longevity risk.
Life ILS’ sponsor roster is a ‘who’s who’ of companies and organisations active in the Life ILS industry.
Register your interest for the Secondary Life Markets Conference | 2025
A consensus exists within biogerontology that some of the mechanisms causing mammalian ageing are known and druggable. These mechanisms will be explained and their potential effects on longevity risk and the disruption of mortality assumptions discussed. However, alpha opportunities also now exist for investors who can integrate biogerontological expertise into their traditional actuarial models.
The longevity and mortality markets are multi-faceted and each has its own idiosyncracies that affect the performance of an investment. The state of the market panel sees three industry leaders from the life settlement, life ILS and pension risk transfer markets provide a helicopter view of what topics, themes or trends are impacting their segment of the longevity and mortality markets currenty.
Life settlements provides investor portfolios with a range of benefits but many of these are either misunderstood or drowned out by perceived risks. In his presentation, Matt Mejia, Managing Director at Preston Capital, offers his perspective on the nuances of the asset class and the outlook for it through the rest of the year and beyond.
Over its history the Life ILS markets have featured a range of investment exposures that have attracted a corresponding range of institutional investors. In this presentation we consider the Life ILS investment opportunity set as it stands in 2025 examining both the supply of risks and institutional investor demands for these risks.
The life insurance industry has undergone significant transformation, particularly in the years following the global financial crisis. The entry of private equity firms and other alternative asset managers has been a key driver of this evolution, reshaping traditional models and investment strategies. This presentation will explore the factors behind this shift, examine its impact on the industry, and consider the potential trajectory of the life insurance market in the years ahead.
Following the three presentations relating to demand and supply dynamics in the life insurance-related markets, Life Risk News’ Greg Winterton hosts a Q&A session where the audience will be able to pose questions to the presenters.
Reinsurance and sidecar structures are gaining momentum in the life insurance industry, offering capital efficiency and access to alternative risk transfer. This panel will examine the drivers behind recent growth, the outlook for continued expansion, and the evolving role of sidecars in life risk financing. Panellists will also explore what investors need to know about structuring, risk-return dynamics, and considerations for entering this specialised but growing market.
The (re)insurance markets are well-used to trading longevity risk. Life and longevity sidecars are now an established concept. What are the new opportunities for other non-traditional participations in longevity risk, and associated assets? How does this link with the world of securitisation, asset-based capital charges and other regulatory considerations/ associated issues in the principal jurisdictions of the UK, Bermuda and the US? This panel discusses both recent and future developments that look set to drive further activity in this market.
This session will first explore the techniques typically used by insurers and reinsurers to model longevity in the pension risk transfer market, with a focus on allowance for socioeconomic factors. It will then go on to consider how that approach may be applicable to the other longevity/mortality markets.
Discover how wealth and longevity are powerfully linked in the life settlement market. This presentation reveals key mortality trends, underwriting considerations, and actionable insights to improve pricing, manage tail risk, and optimize portfolios in today’s investor landscape.
The healthcare industry is paying increasing attention to social determinants of health (“SDOH”). This talk will reveal some of the ways HealthTech company, HDAI, is extracting and using this information in predictive modelling, and how these insights translate to the market for longevity risk.
Folliowing the three presentations relating to mortality modelling in the life risk space, LCP’s Stuart MacDonald hosts a Q&A session where the audience will be able to pose questions to both him and the presenters.